Nikolai Paul Pace1, Celine Ann Grech2, Barbara Vella2, Ruth Caruana3, Josanne Vassallo3. 1. Centre for Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Nikolai Paul Pace, Room 325, Msida, 2080, MSD, Malta. nikolai.p.pace@um.edu.mt. 2. Centre for Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Nikolai Paul Pace, Room 325, Msida, 2080, MSD, Malta. 3. Department of Medicine, Faculty of Medicine and Surgery, University of Malta, Msida, MSD2080, Malta.
Abstract
AIM: To investigate the frequency and spectrum of glucokinase (GCK) mutations in a cohort of adults from an island population having a high prevalence of diabetes mellitus (DM). METHODS: A single-centre cohort study was conducted, including 145 non-obese adults of Maltese-Caucasian ethnicity with impaired fasting glycaemia (IFG) or non-autoimmune diabetes diagnosed before the age of 40 years. Bidirectional sequencing of the GCK coding regions was performed. Genotype-phenotype associations and familial segregation were explored and the effects of missense variants on protein structure were evaluated using computational analysis. RESULTS: Three probands with pathogenic/likely pathogenic GCK variants in the heterozygous state having clinical features consistent with GCK-diabetes were detected. The missense variants have structurally destabilising effects on protein structure. GCK variant carriers exhibited a significantly lower body mass index and serum triglyceride levels when compared to GCK variant non-carriers. CONCLUSIONS: The frequency of GCK-diabetes is approximately 2% in non-obese Maltese adults with diabetes or prediabetes. This study broadens the mutational spectrum of GCK and highlights clinical features that could be useful in discriminating GCK-DM from type 2 DM or prediabetes. It reinforces the need for increased molecular testing in young adults with diabetes having a suspected monogenic aetiology.
AIM: To investigate the frequency and spectrum of glucokinase (GCK) mutations in a cohort of adults from an island population having a high prevalence of diabetes mellitus (DM). METHODS: A single-centre cohort study was conducted, including 145 non-obese adults of Maltese-Caucasian ethnicity with impaired fasting glycaemia (IFG) or non-autoimmune diabetes diagnosed before the age of 40 years. Bidirectional sequencing of the GCK coding regions was performed. Genotype-phenotype associations and familial segregation were explored and the effects of missense variants on protein structure were evaluated using computational analysis. RESULTS: Three probands with pathogenic/likely pathogenic GCK variants in the heterozygous state having clinical features consistent with GCK-diabetes were detected. The missense variants have structurally destabilising effects on protein structure. GCK variant carriers exhibited a significantly lower body mass index and serum triglyceride levels when compared to GCK variant non-carriers. CONCLUSIONS: The frequency of GCK-diabetes is approximately 2% in non-obese Maltese adults with diabetes or prediabetes. This study broadens the mutational spectrum of GCK and highlights clinical features that could be useful in discriminating GCK-DM from type 2 DM or prediabetes. It reinforces the need for increased molecular testing in young adults with diabetes having a suspected monogenic aetiology.
Authors: David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: David Carmody; Rochelle N Naylor; Charles D Bell; Shivani Berry; Jazzmyne T Montgomery; Elizabeth C Tadie; Jessica L Hwang; Siri Atma W Greeley; Louis H Philipson Journal: Acta Diabetol Date: 2016-04-22 Impact factor: 4.280
Authors: C Aloi; A Salina; N Minuto; R Tallone; F Lugani; A Mascagni; O Mazza; M Cassanello; M Maghnie; G d'Annunzio Journal: Acta Diabetol Date: 2017-07-19 Impact factor: 4.280
Authors: Kara K Osbak; Kevin Colclough; Cecile Saint-Martin; Nicola L Beer; Christine Bellanné-Chantelot; Sian Ellard; Anna L Gloyn Journal: Hum Mutat Date: 2009-11 Impact factor: 4.878
Authors: Gaya Thanabalasingham; Aparna Pal; Mary P Selwood; Christina Dudley; Karen Fisher; Polly J Bingley; Sian Ellard; Andrew J Farmer; Mark I McCarthy; Katharine R Owen Journal: Diabetes Care Date: 2012-03-19 Impact factor: 19.112
Authors: Stepanka Pruhova; Petra Dusatkova; Pavel J Kraml; Michal Kulich; Zdena Prochazkova; Jan Broz; Jaroslav Zikmund; Ondrej Cinek; Michal Andel; Oluf Pedersen; Torben Hansen; Jan Lebl Journal: Int J Endocrinol Date: 2013-09-11 Impact factor: 3.257
Authors: Amanda Stride; Beverley Shields; Olivia Gill-Carey; Ali J Chakera; Kevin Colclough; Sian Ellard; Andrew T Hattersley Journal: Diabetologia Date: 2013-10-04 Impact factor: 10.122